The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Race discrimination class action for one of the largest U.S. forest product manufacturers
Represented one of the largest U.S. forest products manufacturers in a suit brought against our client in Alabama Federal court by the EEOC on behalf more
Acquisition for leading desktop publishing software provider
Advised leading desktop publishing software provider in connection with its acquisition of all shares in imaging company. more
Georgia-Pacific Corp. v. The Procter & Gamble Co.
Successfully represented Georgia-Pacific in the expedited arbitration of a case involving false advertising more
Subordinate CMBS certificates in over 150 CMBS securitizations
Represented over a dozen different investors in the acquisition of subordinate CMBS certificates in over 150 CMBS securitizations including more